Corcept Therapeutics Incorporated (CORT)
Solvency ratios
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.23 | 1.16 | 1.13 | 1.09 | 1.11 |
Based on the solvency ratios of Corcept Therapeutics Inc provided in the table, it is evident that the company has maintained a consistent trend of low debt levels relative to its assets, capital, and equity over the past five years. The debt-to-assets, debt-to-capital, and debt-to-equity ratios have all been at 0.00, indicating that the company has not relied heavily on debt financing to fund its operations and investments.
Furthermore, the financial leverage ratio has shown a slight upward trend, increasing from 1.09 in 2020 to 1.23 in 2023. This suggests that the company's level of financial leverage has been on the rise, although it still remains relatively moderate. A financial leverage ratio above 1 indicates that the company has more debt than equity in its capital structure.
Overall, the solvency ratios reflect Corcept Therapeutics Inc's strong financial position and conservative use of debt, which may indicate a lower risk of financial distress and potential stability in the long term.
Coverage ratios
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Interest coverage | — | 31.67 | 34.62 | 22.74 | 22.01 |
As the interest coverage ratio values are missing for the years 2019 to 2023, it is not possible to assess Corcept Therapeutics Inc's ability to meet its interest obligations through its operating profits. The interest coverage ratio is a key financial metric that indicates a company's capacity to pay interest expense on outstanding debt. Without this information, it is challenging to evaluate the company's financial health and leverage position accurately. Investors and analysts should seek updated financial statements or disclosures from Corcept Therapeutics Inc to perform a comprehensive analysis of its interest coverage ratio in order to make informed investment decisions.